HOPE CHIODI: Open Payments
NPI 1457805749 · STEUBENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 12 payments from 12 companies in 2025. Trend: 2023 $454 · 2024 $338 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 1 | $96 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| ABBVIE INC. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Acrotech Biopharma Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| ARRAY BIOPHARMA INC | 1 | $25 |
| EMD Serono, Inc. | 1 | $23 |
Products named: XT CDX, LYNOZYFIC, Onivyde, VENCLEXTA, Enhertu, BELEODAQ, PLUVICTO, VERZENIO.
Industry payments across OH — which companies pay providers there.
